Cusumano VT - Search Results

1

Early-Onset Colorectal Cancer Is Associated with a Lower Risk of Metachronous Advanced Neoplasia than Traditional-Onset Colorectal Cancer.

Chen FW, Yang L, Cusumano VT, Chong MC, Lin JK, Partida D, May FP. Chen FW, et al. Among authors: cusumano vt. Dig Dis Sci. 2022 Mar;67(3):1045-1053. doi: 10.1007/s10620-021-06902-w. Epub 2021 Mar 15. Dig Dis Sci. 2022. PMID: 33721159

2

Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs.

Cusumano VT, May FP. Cusumano VT, et al. J Gen Intern Med. 2020 Jun;35(6):1870-1874. doi: 10.1007/s11606-020-05728-y. Epub 2020 Mar 3. J Gen Intern Med. 2020. PMID: 32128688 Free PMC article.

3

Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy.

Cusumano VT, Corona E, Partida D, Yang L, Yu C, May FP. Cusumano VT, et al. BMC Gastroenterol. 2020 Apr 19;20(1):115. doi: 10.1186/s12876-020-01262-7. BMC Gastroenterol. 2020. PMID: 32306919 Free PMC article.

4

Identifying Quality Gaps in Preventive Care for Outpatients With Cirrhosis Within a Large, Academic Health Care System.

Kardashian A, Patel AA, Aby ES, Cusumano VT, Soroudi C, Winters AC, Wu E, Beah P, Delshad S, Kim N, Yang L, May FP. Kardashian A, et al. Among authors: cusumano vt. Hepatol Commun. 2020 Sep 9;4(12):1802-1811. doi: 10.1002/hep4.1594. eCollection 2020 Dec. Hepatol Commun. 2020. PMID: 33305151 Free PMC article.

5

Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.

Cusumano VT, Myint A, Corona E, Yang L, Bocek J, Lopez AG, Huang MZ, Raja N, Dermenchyan A, Roh L, Han M, Croymans D, May FP. Cusumano VT, et al. Dig Dis Sci. 2021 Nov;66(11):3760-3768. doi: 10.1007/s10620-021-06866-x. Epub 2021 Feb 20. Dig Dis Sci. 2021. PMID: 33609211

6

Pneumococcal Vaccination Recommendation and Completion Rates Among Patients With Inflammatory Bowel Disease and Barriers to Vaccination.

Dasharathy SS, May FP, Myint A, Yang L, Rahal HK, Cusumano V, Kozan PA, Lowe SC, Beah PY, Limketkai BN, Sauk JS. Dasharathy SS, et al. J Clin Gastroenterol. 2023 Nov-Dec 01;57(10):1031-1037. doi: 10.1097/MCG.0000000000001783. Epub 2023 Jan 19. J Clin Gastroenterol. 2023. PMID: 36728018

7

Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal Fistulae.

Maas L, Gao R, Cusumano V, Spartz E, Chowdhury R, Krishna M, Lazarev M, Melia J, Selaru F, Sharma S, Limketkai B, Parian A. Maas L, et al. Dig Dis Sci. 2023 Oct;68(10):3994-4000. doi: 10.1007/s10620-023-08060-7. Epub 2023 Aug 4. Dig Dis Sci. 2023. PMID: 37540392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters